Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: An extended-release, abuse-deterrent formulation
Authors:
- 1 July 2014
- journal article
- research article
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 10 (4) , 233-246
Abstract
In vitro: To assess the effect of common crushing techniques on particle size reduction (PSR) and in vitro drug-release kinetics of oxycodone DETERx® (herein DETERx) and of a commercially available oxycodone extended-release (ER) tablet. In vivo: To evaluate the impact of the most effective manipulation method identified in the in vitro study and the effect of chewing on the pharmacokinetics (PK) of DETERx relative to oxycodone solution. In vitro: Mechanical manipulation of dosage forms using common household utensils. In vivo: Open-label, randomized, active-controlled, crossover PK study. In vivo: Forty-four healthy male and female volunteers. In vitro: DETERx capsule contents and marketed comparator tablets were subjected to manipulation (crushing) using 10 different household utensils. Particle size and dissolution analysis were conducted. In vivo: Subjects were randomly assigned to receive DETERx 40-mg capsules intact, crushed, or chewed or oxycodone solution. Serial blood samples were drawn for PK assessment. In vitro: The utensils used to manipulate DETERx capsule contents were either ineffective in reducing the particle size or produced only a small change in the median particle size and dissolution rate relative to the marketed comparator. In vivo: DETERx intact capsules provided significantly lower Cmax and longer Tmax values than oxycodone solution. Manipulation of DETERx by crushing (using the most effective method established in vitro) or chewing resulted in bioequivalent plasma concentration-time profiles to the intact dosage form. These mechanical manipulation and PK studies demonstrated that DETERx beads retained their ER properties after mechanical tampering and chewing by study subjects.Keywords
This publication has 12 references indexed in Scilit:
- An iterative model for in vitro laboratory assessment of tamper deterrent formulationsDrug and Alcohol Dependence, 2013
- Abuse Rates and Routes of Administration of Reformulated Extended-Release Oxycodone: Initial Findings From a Sentinel Surveillance Sample of Individuals Assessed for Substance Abuse TreatmentThe Journal of Pain, 2013
- Strategies to Reduce the Tampering and Subsequent Abuse of Long-acting Opioids: Potential Risks and Benefits of Formulations With Physical or Pharmacologic Deterrents to TamperingMayo Clinic Proceedings, 2012
- Tampering with Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and SolutionsThe American Journal of Drug and Alcohol Abuse, 2011
- Internet-based Survey of Nonmedical Prescription Opioid Use in the United StatesThe Clinical Journal of Pain, 2008
- Dose form modification – a common but potentially hazardous practice. A literature review and study of medication administration to older psychiatric inpatientsInternational Psychogeriatrics, 2008
- Survey of select practice behaviors by primary care physicians on the use of opioids for chronic painCurrent Medical Research and Opinion, 2006
- Primary care provider concerns about management of chronic pain in community clinic populationsJournal of General Internal Medicine, 2006
- Psychiatrie and Pain Characteristics of Prescription Drug Abusers Entering Drug RehabilitationJournal of Pain & Palliative Care Pharmacotherapy, 2006
- Differential Effects of Food on the Bioavailability of Controlled-Release Oxycodone Tablets and Immediate-Release Oxycodone SolutionJournal of Pharmaceutical Sciences, 1996